The epidemiology of skin cancer

被引:289
作者
Gloster, HM
Brodland, DG
机构
[1] Department of Dermatology, Mayo Clinic, Rochester, MN
[2] Department of Dermatology, Mayo Clinic, Rochester, MN 55095, 200 First Street, SW
关键词
D O I
10.1111/j.1524-4725.1996.tb00312.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND. The incidence of skin cancer is increasing at an alarming rate. OBJECTIVE. TO discuss current epidemiologic data concerning the incidence, morbidity, environmental influences, predisposing, host conditions, precursor lesions, and prevention of melanoma and nonmelanoma (basal and squamous cell) skin cancer. METHODS. The current literature was reviewed in order to provide current epidemiologic data for melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC). RESULTS. Skin cancer is exceedingly common and the incidence is rising rapidly. Although the mortality rate for nonmelanoma skin cancer (NMSC) is decreasing, that of melanoma is increasing. Both NMSC and melanoma are associated with significant morbidity. Whereas chronic sun exposure is the main cause of NMSC, the development of melanoma appears to be related to intense, intermittent sun exposure. Ozone depletion has contributed to rising incidence rates of both NMSC and melanoma. In contrast to NMSC, there is not a direct relationship between ultraviolet radiation and melanoma. Genetic susceptibility significantly increases the lifetime risk of acquiring melanoma. There is no precursor lesion for BCC. Precursor lesions for invasive SCC include actinic keratoses and SCC in situ. Melanoma may arise from benign nevi and dysplastic nevi. Prevention of melanoma and NMSC is extremely important since prognosis improves with early detection. Prevention may be achieved by educating patients and physicians how to detect skin cancers early and by decreasing or eliminating exposure to ultraviolet light. CONCLUSION. The incidence of skin cancer has reached epidemic proportions. Only through heroic efforts by health care professionals and the general public to prevent the development or progression of skin cancer will this epidemic be abated.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 160 条
[41]  
GLOECKLERRIES LA, 1990, 902789 NIH
[42]  
Green A, 1982, Australas J Dermatol, V23, P105, DOI 10.1111/j.1440-0960.1982.tb00739.x
[43]  
Green A, 1992, Epithelial Cell Biol, V1, P47
[44]   COMMON ACQUIRED NAEVI AND THE RISK OF MALIGNANT-MELANOMA [J].
GREEN, A ;
MACLENNAN, R ;
SISKIND, V .
INTERNATIONAL JOURNAL OF CANCER, 1985, 35 (03) :297-300
[45]   HIGH-RISK OF MALIGNANT-MELANOMA IN MELANOMA-PRONE FAMILIES WITH DYSPLASTIC NEVI [J].
GREENE, MH ;
CLARK, WH ;
TUCKER, MA ;
KRAEMER, KH ;
ELDER, DE ;
FRASER, MC .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (04) :458-465
[46]   MALIGNANT-MELANOMA IN RENAL-TRANSPLANT RECIPIENTS [J].
GREENE, MH ;
YOUNG, TI ;
CLARK, WH .
LANCET, 1981, 1 (8231) :1196-1199
[47]   ACQUIRED PRECURSORS OF CUTANEOUS MALIGNANT-MELANOMA - THE FAMILIAL DYSPLASTIC NEVUS SYNDROME [J].
GREENE, MH ;
CLARK, WH ;
TUCKER, MA ;
ELDER, DE ;
KRAEMER, KH ;
GUERRY, D ;
WITMER, WK ;
THOMPSON, J ;
MATOZZO, I ;
FRASER, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (02) :91-97
[48]   CUTANEOUS MALIGNANT NEOPLASMS IN PATIENTS WITH RENAL-TRANSPLANTS [J].
GUPTA, AK ;
CARDELLA, CJ ;
HABERMAN, HF .
ARCHIVES OF DERMATOLOGY, 1986, 122 (11) :1288-1293
[49]   SKIN-CANCER IN BLACKS IN THE UNITED-STATES [J].
HALDER, RM ;
BANG, KM .
DERMATOLOGIC CLINICS, 1988, 6 (03) :397-405
[50]   DYSPLASTIC NEVI AS RISK MARKERS OF SPORADIC (NONFAMILIAL) MELANOMA - A CASE-CONTROL STUDY [J].
HALPERN, AC ;
GUERRY, D ;
ELDER, DE ;
CLARK, WH ;
SYNNESTVEDT, M ;
NORMAN, S ;
AYERLE, R .
ARCHIVES OF DERMATOLOGY, 1991, 127 (07) :995-999